Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...
3don MSN
Vanda narrows 2025 revenue guidance to $210M-$230M amid Fanapt growth and strategic investments
Discover Vanda Pharmaceuticals' Q3 2025 results: strong Fanapt growth, updated guidance, and pipeline milestones.
Swiggy’s quick commerce business Swiggy Instamart will eventually move to an inventory-led model, like its rival ...
AS part of the modernisation of management of drugs and medical supplies in Guyana, Minister of Health Dr Frank Anthony has said that advanced warehousing and ...
DexCom, Inc. DXCM is scheduled to report third-quarter 2025 resultson Oct. 30, after the closing bell. In the last reported ...
From telemedicine hotlines to AI-powered hospital systems, digital innovation is reshaping Bangladesh’s healthcare landscape, bringing doctors, medicine, and medical advice to even the most remote vil ...
Return to shareholders -- $1.4 billion was returned to shareholders as of fiscal Q3 2025 through dividends and share ...
By rethinking operational models, radiopharma leaders can mitigate risks, increase efficiency and ensure reliable access to ...
Q3 2025 Earnings Call Transcript October 30, 2025 DexCom, Inc. beats earnings expectations. Reported EPS is $0.61, ...
Q3 2025 Earnings Call Transcript October 29, 2025 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...
Dis-Chem Pharmacies Limited (Incorporated in the Republic of South Africa) (Registration number 2005/009766/06) JSE share code: DCP ISIN: ZAE000227831 (‘Dis-Chem’ or ‘the Company’ or ‘the Group’) ...
Guam Memorial Hospital leadership on Monday backed a bill to give GMH about $8.1 million it’s owed from the Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results